[1]尹畅王建伟刘倩楠张勤张振伟马旭东.以单病种过程质量管理促进临床诊疗同质化[J].中国卫生质量管理,2022,29(07):012-14.[doi:10.13912/j.cnki.chqm.2022.29.7.04 ]
 YIN Chang,WANG Jianwei,LIU Qiannan.Promoting Homogenization of Clinical Diagnosis and Treatment by Process Quality Management of Single Disease[J].Chinese Health Quality Management,2022,29(07):012-14.[doi:10.13912/j.cnki.chqm.2022.29.7.04 ]
点击复制

以单病种过程质量管理促进临床诊疗同质化
分享到:

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第29卷
期数:
2022年07期
页码:
012-14
栏目:
特别关注
出版日期:
2022-07-28

文章信息/Info

Title:
Promoting Homogenization of Clinical Diagnosis and Treatment by Process Quality Management of Single Disease
作者:
尹畅王建伟刘倩楠张勤张振伟马旭东
国家卫生健康委医院管理研究所医疗质量监测与控制研究室
Author(s):
YIN ChangWANG JianweiLIU Qiannan
Medical Quality Monitoring and Control Laboratory, National Institute of Hospital Administration
关键词:
单病种过程质量管理同质化医疗质量
Keywords:
Single Disease Process Quality Management HomogenizationMedical Quality
分类号:
R197.323
DOI:
10.13912/j.cnki.chqm.2022.29.7.04
文献标志码:
A
摘要:
单病种质量管理丰富了过程质量管理的内涵,是提升医疗质量管理水平的重要手段。利用单病种过程质量管理实现医疗质量管理同质化,需要从临床诊疗工作同质化、数据同质化、医疗质量评价同质化三方面发力,引导医疗机构运用单病种质量监测信息项开展国家、省级和院内、院际间的质量比较,从而推进临床诊疗过程质量管理同质化。
Abstract:
Single disease quality management has enriched the connotation of process quality management and it is an important means to improve the level of medical quality management. The realization of homogenization of medical quality management by process quality management of single disease needs efforts from three aspects: clinical diagnosis and treatment homogenization,data homogenization, and medical quality evaluation homogenization, which guides the medical institutions to use single disease quality monitoring information items on quality comparisons with national and provincial levels, within and between hospitals, so as to promote the homogenization of quality management of clinical diagnosis and treatment process.

参考文献/References:

[1]车永茂,吴丽娟,徐道亮,等.基于信息技术的医疗质量管理路径探索[J].中国卫生质量管理,2014,21(2):60-62. [2]陈晨,张侃.深化“三好一满意”活动举措全面提升医院服务水平[J].中国卫生质量管理,2013,20(6):60-62.[3]国家卫生健康委员会.医疗质量管理办法:第10号委令[EB/OL].(2016-10-14)[2021-12-07].http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=ae125f28eef24ca7aac57c8ec530 c6d2. [4]MAN S,SCHOLD JD,UCHINO K.Impact of stroke center certification on mortality after ischemic stroke:the medicare cohort from 2009 to 2013[J].Stroke,2017,48(9):2527-2533. [5]MAYS N.Evaluating the labour government's English NHS health system reforms:the 2008 darzi reforms[J].J Health Serv Res Policy,2013,18(2 Suppl):1-10. [6]BEST M,NEUHAUSER D.Avedis Donabedian:father of quality assurance and poet[J].Qual Saf Health Care,2004,13(6):472-473. [7]DONABEDIAN A.Evaluating the quality of medical care[J].The Milbank Quarterly,2005,83(4):691-729. [8]曾慧慧,蒋荣猛,马旭东.我国单病种质量管理历史沿革与思考[J].中国卫生质量管理,2021,28(10):21-23. [9]王吉善,张振伟.开展病种质量管理提高医疗服务水平[J].中国医院,2010,14(5):1-3. [10]蔡慧,胡龙军,丁明明,等.基于三级综合医院病种特点的临床路径管理[J].中国卫生质量管理,2022,29(3):30-32.

相似文献/References:

[1]刘红梅解翠张玉莲李媛孙杨周忠良刘晓梅.单病种护理质量标准在急性心肌梗死患者中的应用[J].中国卫生质量管理,2016,23(05):060.[doi:10.13912/j.cnki.chqm.2016.23.5.18]
[2]赵素平 姚溪 张玉莲 高京华.单病种护理质量标准在老年消化性溃疡患者中的应用[J].中国卫生质量管理,2017,24(05):078.[doi:10.13912/j.cnki.chqm.2017.24.5.25]
[3]吴越 李恒新 张雅娟 李刚 刘南 高建民.单病种精细化防治效果分析:以狂犬病为例[J].中国卫生质量管理,2017,24(06):109.[doi:10.13912/j.cnki.chqm.2017.24.6.36]
[4]曾慧慧蒋荣猛马旭东.我国单病种质量管理历史沿革及思考[J].中国卫生质量管理,2021,28(10):021.[doi:10.13912/j.cnki.chqm.2021.28.10.06 ]
 ZENG Huihui,JIANG Rongmeng,MA Xudong.Historical Evolution and Thinking of Single Disease Quality Management in China[J].Chinese Health Quality Management,2021,28(07):021.[doi:10.13912/j.cnki.chqm.2021.28.10.06 ]
[5]马旭东王建伟张超黎张振伟尹畅.我国单病种质量管理工作回顾及思考[J].中国卫生质量管理,2022,29(07):001.[doi:10.13912/j.cnki.chqm.2022.29.7.01 ]
 MA Xudong,WANG Jianwei,ZHANG Chaoli.Review and Thinking on the Quality Management of Single Disease in China[J].Chinese Health Quality Management,2022,29(07):001.[doi:10.13912/j.cnki.chqm.2022.29.7.01 ]
[6]尹畅王建伟张超黎张振伟马旭东.医疗机构落实国家单病种质量管理工作的思路探讨[J].中国卫生质量管理,2022,29(07):005.[doi:10.13912/j.cnki.chqm.2022.29.7.02 ]
 YIN Chang,WANG Jianwei,ZHANG Chaoli.Discussion on Working Ideas for Medical Institutions in Implementing Single Disease Quality Management[J].Chinese Health Quality Management,2022,29(07):005.[doi:10.13912/j.cnki.chqm.2022.29.7.02 ]
[7]刘倩楠聂静张振伟尹畅.单病种过程质量评价现状及思考[J].中国卫生质量管理,2022,29(07):008.[doi:10.13912/j.cnki.chqm.2022.29.7.03 ]
 LIU Qiannan,NIE Jing,ZHANG Zhenwei.The Status and Thinking of Process Quality Evaluation of Single Disease[J].Chinese Health Quality Management,2022,29(07):008.[doi:10.13912/j.cnki.chqm.2022.29.7.03 ]
[8]徐莉顾逸君邵琰婷张涛.单病种质量管理信息化平台建设与应用[J].中国卫生质量管理,2022,29(07):015.[doi:10.13912/j.cnki.chqm.2022.29.7.05 ]
 XU Li,GU Yijun,SHAO Yanting.Construction and Application of Single Disease Quality Management Informatization Platform[J].Chinese Health Quality Management,2022,29(07):015.[doi:10.13912/j.cnki.chqm.2022.29.7.05 ]
[9]潘伟华许健穆嘉盛黄宇飞沈鸿楼汪鑫欧阳田岽.应用人工智能提升单病种质量管理水平[J].中国卫生质量管理,2022,29(07):019.[doi:10.13912/j.cnki.chqm.2022.29.7.06 ]
 PAN Weihua,XU Jian,MU Jiasheng.Improving the Quality Management Level of Single Disease Through Artificial Intelligence[J].Chinese Health Quality Management,2022,29(07):019.[doi:10.13912/j.cnki.chqm.2022.29.7.06 ]
[10]邓明时黎明林伟龙杨谨成安宇杨娟周成诚杨文静.我国肿瘤单病种质控路径实践与展望[J].中国卫生质量管理,2022,29(11):006.[doi:10.13912/j.cnki.chqm.2022.29.11.02 ]
 DENG Ming,SHI Liming,LIN Weilong.Practice and Prospect of Quality Control Path of Single Disease of Tumor in China[J].Chinese Health Quality Management,2022,29(07):006.[doi:10.13912/j.cnki.chqm.2022.29.11.02 ]

更新日期/Last Update: 2022-07-28